FDA NDC Directory · JSON-LD · Markdown

Lansoprazole

NDC 11673-324 · HUMAN OTC DRUG · CAPSULE, DELAYED RELEASE

Labeler / ManufacturerTarget Corporation
Marketing categoryAbbreviated NDA (generic) · App ANDA202194
Dosage form / routeCAPSULE, DELAYED RELEASE · ORAL
Active ingredientsLANSOPRAZOLE (15 mg/1)
Marketing started20220412
Package count1

External sources

Source: openFDA. Public-domain (CC0).